Skip to main content

Table 2 Descriptive statistics of training data set in our primary analysis

From: Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy

  

Incident Cardiac Dysfunction

 

Overall

No

Yes

P-value

n

270

245

25

 

Age at Dx (mean (SD))

57.69 (12.95)

57.80 (13.11)

56.56 (11.39)

0.649

Stroke (%)

13 (4.9)

11 (4.6)

2(8.0)

0.786

Diabetes (%)

37 (13.9)

30 (12.4)

7(28.0)

0.066

Adriamycin (%)

16 (6.0)

11 (4.6)

5(20.0)

0.008